Proteomics International Pty Ltd

Site

WA Proteomics Facility

Accreditation No.

16838

Site No.

18237

Date of Accreditation

16 Jul 2009

Address

Harry Perkins Institute of Medical Research, Level 1 QQ Block, QEII Medical Centre, 6 Verdun Street
Nedlands, WA 6009
Australia

proteomics.com.au

Contact

Dr Jason Ito P: +61 (08) 93891992

Availability

Services available to external clients

Proteomics International Pty Ltd address map

Scope of Accreditation

Print scopes
WA Proteomics Facility

ISO/IEC 17025 (2017)

Food and Beverage

Service Product Determinant Technique Procedure
Analysis of physical and nutritional characteristics Liquid milk; Milk concentrates; Milk powder; Milk protein concentrate; Milk protein isolate A2 milk protein HPLC  A2 Protein Determination in Client Supplied Milk Samples  (in-house method 0-036)

ISO/IEC 17025 (2017)

Healthcare, Pharmaceutical and Media Products

Service Product Determinant Technique Procedure
Analysis for physical and chemical characteristics of human and veterinary medicines including vaccines Biological or environmental sample containing protein; Pharmaceutical preparations; Protein derivative and small molecule (<900 Daltons) in liquid and solid format Physiochemical tests Gel electrophoresis; HPLC; LC-MS; UV-vis spectrophotometry Protein ID (in-house method 1-012) LC-MS
De Novo Seq (in-house method 1-012) LC-MS
Proteome Mapping (in-house method 1-016) LC-MS
1-D Gel Electrophoresis (in-house method 2-004)
Intact Mass Analysis (in-house method 1-016) LC-MS
N-terminal Sequencing (in-house method 1-012) LC-MS
Disulfide Bridge (in-house method 1-012) LC-MS
N-Glycan Analysis (in-house method 0-048) Electrophoresis
Isoelectric Focusing IEF (in-house method 2-010) Electrophoresis
UV Vis/Fluorescent Spectral Analysis (in-house method 0-040)
Charge Variant Analysis WCX (in-house method 3-001) HPLC
Hydrophobic Interaction (in-house method 3-001) HPLC
Chromatography HIC (in-house method 3-001) HPLC
Size Exclusion SEC (in-house method 3-001) HPLC
Pharmacokinetic Monitoring (in-house method 1-005, 1-015) LC-MS
Proteome Quantitation  (in-house method 1-016) LC-MS
Targeted Analysis MRM/SRM (in-house method 1-015, 1-017. 1-018) LC-MS
Analysis in support of clinical trials and/or pre-clinical studies Animal biological samples; Human biological samples Development of biomarkers; Therapeutic drug discovery Electrophoresis; HPLC; LC-MS
Analysis in support of research Biological samples; Human biological samples; Liquid pharmaceutical preparations; Recombinant molecules; Solid pharmaceutical preparations Discovery and development of biomarkers and biosimilars; Physiochemical characterisation; Therapeutic drug discovery Electrophoresis; HPLC; LC-MS
Analysis in support of the development and/or optimisation of new assays, devices or techniques Biological samples; Human biological samples; Liquid pharmaceutical preparations; Recombinant molecules; Solid pharmaceutical preparations Development of biomarkers and biosimilars; Physiochemical characterisation; Therapeutic drug discovery Electrophoresis; HPLC; LC-MS
Bioinformatic analysis and interpretation Protein quantitation data from LC-MS analysis; Protein sequencing data from LC-MS analysis Data annotation and interpretation; Differential biomarker identification Bioinformatic analysis - Protein identification and relative protein expression software in-house method 1-008, 7-006, 8-004, 8-006, 8-007, 8-008

Biological analysis of other healthcare or pharmaceutical products and accessories Biological or environmental sample containing protein; Protein derivative and small molecule (<900 Daltons) in liquid and solid format Physicochemical tests Electrophoresis; HPLC; LC-MS; Mass spectrometry (MS)
Protein ID (in-house method 1-012) LC-MS
De Novo Seq (in-house method 1-012) LC-MS
Proteome Mapping (in-house method 1-016) LC-MS
1-D Gel Electrophoresis (in-house method 2-004)
Intact Mass Analysis (in-house method 1-016) LC-MS
N-terminal Sequencing (in-house method 1-012) LC-MS
Disulfide Bridge (in-house method 1-012) LC-MS
N-Glycan Analysis (in-house method 0-048) Electrophoresis
Isoelectric Focusing IEF (in-house method 2-010) Electrophoresis
UV Vis/Fluorescent Spectral Analysis (in-house method 0-040)
Charge Variant Analysis WCX (in-house method 3-001) HPLC
Hydrophobic Interaction (in-house method 3-001) HPLC
Chromatography HIC (in-house method 3-001) HPLC
Size Exclusion SEC (in-house method 3-001) HPLC
Pharmacokinetic Monitoring (in-house method 1-005, 1-015) LC-MS
Proteome Quantitation  (in-house method 1-016) LC-MS
Targeted Analysis MRM/SRM (in-house method 1-015, 1-017. 1-018) LC-MS

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.